DIVIS LABORATORIES Announces Quarterly Results (4QFY20); Net Profit Up 35.4%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES Announces Quarterly Results (4QFY20); Net Profit Up 35.4%
Mon, 8 Jun

DIVIS LABORATORIES has announced its results for the quarter ended March 2020. Here is a detailed performance review of the same:

DIVIS LABORATORIES Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-19*
3
Dec-19*
3
Mar-20*
QoQ ChangeYoY Change
Net SalesRs m12,56413,90513,762-1.0%9.5%
Other incomeRs m41740376589.8%83.4%
TurnoverRs m12,98214,30814,5281.5%11.9%
ExpensesRs m8,4538,9369,2763.8%9.7%
Gross profitRs m4,1114,9694,486-9.7%9.1%
DepreciationRs m4234674956.1%17.0%
InterestRs m1164-74.2%300.0%
Profit before taxRs m4,1044,8894,752-2.8%15.8%
TaxRs m1,2101,282834-34.9%-31.1%
Profit after taxRs m2,8943,6073,9188.6%35.4%
Gross profit margin%32.735.732.6
Effective tax rate%29.526.217.6
Net profit margin%22.325.227.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 9.5% on a year-on-year (YoY) basis. The expenses were up by 9.7% YoY during the same period.
  • The company's operating profit increased by 9.1% YoY during the quarter. Consequently, operating profit margins remained same and stood at 32.6% in 4QFY20.
  • Depreciation charges increased by 17.0% and finance costs increased by 300.0% YoY, respectively.
  • Other income increased by 83.4% YoY during the quarter.
  • Net profit for the quarter increased by 35.4% YoY. Net profit margins during the quarter increased from 22.3% in 4QFY19 to 27.0% in 4QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 1.0% on a quarter-on-quarter (QoQ) basis. The expenses were up by 3.8% QoQ during the same period.
  • The company's operating profit declined by 9.7% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 32.6% in 4QFY20 as against 35.7% in 3QFY19.
  • Net profit for the quarter increased by 8.6% QoQ, while net profit margins increased from 25.2% in 3QFY19 to 27.0% in 4QFY20.

To see how DIVIS LABORATORIES has performed over the last eight quarters,please visit here.

Revealed: Top 3 Stocks for 2020 and Beyond

DIVIS LABORATORIES Share Price Performance

Over the last one year,DIVIS LABORATORIES share price has moved up from Rs 1,564.4 to Rs 2,356.7, registering a Gain of Rs 792.3 or around 50.6%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 16,113.5 (down 0.3%). Over the last one year it has moved up from 13,038.9 to 16,113.5, a gain of 3,075 points (up 23.6%).

Overall, the S&P BSE SENSEX is down 12.0% over the year.

Current Valuations

At the current price of Rs 2,356.7, the price to earnings (P/E) ratio of DIVIS LABORATORIES stands at 45.4 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 9.0 times.

Equitymaster requests your view! Post a comment on "DIVIS LABORATORIES Announces Quarterly Results (4QFY20); Net Profit Up 35.4%". Click here!

  

Related Views on News

DIVIS LABORATORIES at All Time High; BSE HEALTHCARE Index Up 1.1% (Market Updates)

Aug 6, 2020 | Updated on Aug 6, 2020

DIVIS LABORATORIES share price has hit an all time high at Rs 2,738 (up 2.2%). The BSE HEALTHCARE Index is up by 1.1%. Among the top gainers in the BSE HEALTHCARE Index today are DIVIS LABORATORIES (up 2.2%) and PROCTER & GAMBLE HEALTH (up 0.3%). The top losers include DR. REDDYS LAB and PFIZER (down 0.3%).

DIVIS LABORATORIES Announces Quarterly Results (3QFY20); Net Profit Down 4.9% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (down 4.9% YoY). Sales on the other hand came in at Rs 14 bn (up 3.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (2QFY20); Net Profit Down 10.3% (Quarterly Result Update)

Nov 11, 2019 | Updated on Nov 11, 2019

For the quarter ended September 2019, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (down 10.3% YoY). Sales on the other hand came in at Rs 14 bn (up 12.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

More Views on News

Most Popular

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio(Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

Before You Buy Your First Electric Vehicle Consider Buying this Stock(Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Gold or Silver: Which One Should You Buy Now?(Fast Profits Daily)

Jul 24, 2020

Silver and gold are both vying for your attention. Which is the better trade today?

A Zero Loss Strategy that Also Maximizes Returns in Volatile Stock Markets(Views On News)

Jul 24, 2020

Here's how to never lose money in stock markets.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Aug 6, 2020 (Close)

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES - ACTAVIS COMPARISON

COMPARE DIVIS LABORATORIES WITH

MARKET STATS